DE69901690T2 - Verwendung von vip analoge für vorbeugung und behandlung von gehirnbeschädigungen von menschlichen neugeborenen - Google Patents

Verwendung von vip analoge für vorbeugung und behandlung von gehirnbeschädigungen von menschlichen neugeborenen

Info

Publication number
DE69901690T2
DE69901690T2 DE69901690T DE69901690T DE69901690T2 DE 69901690 T2 DE69901690 T2 DE 69901690T2 DE 69901690 T DE69901690 T DE 69901690T DE 69901690 T DE69901690 T DE 69901690T DE 69901690 T2 DE69901690 T2 DE 69901690T2
Authority
DE
Germany
Prior art keywords
lys
vip
preventing
brain damage
treating brain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69901690T
Other languages
English (en)
Other versions
DE69901690D1 (de
Inventor
Pierre Gressens
Patrick Robberecht
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Assistance Publique Hopitaux de Paris APHP
Original Assignee
Assistance Publique Hopitaux de Paris APHP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assistance Publique Hopitaux de Paris APHP filed Critical Assistance Publique Hopitaux de Paris APHP
Application granted granted Critical
Publication of DE69901690D1 publication Critical patent/DE69901690D1/de
Publication of DE69901690T2 publication Critical patent/DE69901690T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2278—Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
DE69901690T 1998-03-13 1999-03-12 Verwendung von vip analoge für vorbeugung und behandlung von gehirnbeschädigungen von menschlichen neugeborenen Expired - Fee Related DE69901690T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9803125A FR2775902B1 (fr) 1998-03-13 1998-03-13 Utilisation d'analogues du vip dans la prevention et le traitement des lesions cerebrales du nouveau-ne humain
PCT/FR1999/000563 WO1999047159A1 (fr) 1998-03-13 1999-03-12 Utilisation d'analogues du vip dans la prevention et le traitement des lesions cerebrales du nouveau-ne humain

Publications (2)

Publication Number Publication Date
DE69901690D1 DE69901690D1 (de) 2002-07-11
DE69901690T2 true DE69901690T2 (de) 2003-02-13

Family

ID=9524030

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69901690T Expired - Fee Related DE69901690T2 (de) 1998-03-13 1999-03-12 Verwendung von vip analoge für vorbeugung und behandlung von gehirnbeschädigungen von menschlichen neugeborenen

Country Status (7)

Country Link
EP (1) EP1061945B1 (de)
AT (1) ATE218363T1 (de)
CA (1) CA2322018A1 (de)
DE (1) DE69901690T2 (de)
ES (1) ES2178393T3 (de)
FR (1) FR2775902B1 (de)
WO (1) WO1999047159A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6972319B1 (en) 1999-09-28 2005-12-06 Bayer Pharmaceuticals Corporation Pituitary adenylate cyclase activating peptide (PACAP)receptor 3 (R3) agonists and their pharmacological methods of use
SK5552002A3 (en) * 1999-09-28 2003-05-02 Bayer Ag Pituitary adenylate cyclase activating peptide (PACAP) receptor 3 (R3) agonists and their pharmacological methods of use
US7507714B2 (en) 2000-09-27 2009-03-24 Bayer Corporation Pituitary adenylate cyclase activating peptide (PACAP) receptor 3 (R3) agonists and their pharmacological methods of use
WO2009043447A2 (en) * 2007-09-11 2009-04-09 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL105061A (en) * 1993-03-16 2000-11-21 Yeda Res & Dev Pharmaceutical compositions for the treatment of neurodegenerative diseases comprising VIP analogues and fragments thereof
DE69735991D1 (de) * 1996-02-09 2006-07-06 Hoffmann La Roche Herstellung eines vip-analogen

Also Published As

Publication number Publication date
FR2775902A1 (fr) 1999-09-17
EP1061945A1 (de) 2000-12-27
ES2178393T3 (es) 2002-12-16
FR2775902B1 (fr) 2001-05-11
EP1061945B1 (de) 2002-06-05
ATE218363T1 (de) 2002-06-15
CA2322018A1 (fr) 1999-09-23
WO1999047159A1 (fr) 1999-09-23
DE69901690D1 (de) 2002-07-11

Similar Documents

Publication Publication Date Title
ATE352617T1 (de) Lösliche polypeptidfraktionen des lag-3-proteins; verfahren zur herstellung; therapeutische zusamensetzung; antiidiotypischer antikörper
ATE266043T1 (de) Peptidanaloge des menschlichen basischen myelinproteins
HUP0100928A2 (hu) Humán inzulin B láncának részletét tartalmazó peptidanalógok, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
ATE413189T1 (de) Verfahren und zusammensetzungen zur behinderung der vervielfältigung von hiv-1
GR3019901T3 (en) Osteoinductive pharmaceutical formulations
DE69224622T2 (de) Herstellung von prothrombinzeit-reagenzien aus rekombinantem menschlichem gewebefaktor und sythetischen phospholipiden
DE68929043T2 (de) Für androgen-rezeptor-protein kodierende dna
ATE328901T1 (de) Verfahren für die behandlung der multiplen sklerose mittels peptidanalogen des menschlichen basischen myelinproteins
DE60331546D1 (de) Verwendung von aspartic proteasen in den bereichen kosmetik und behandlung
HU9200548D0 (en) Improved activity process of recombined proteins
ATE273997T1 (de) Zyklische hexapeptid somatostatin analoga
NO920125L (no) Fremgangsmaate for aa bestemme den funksjonelle aktivitetentil fritt protein s eller protein c i en plasmaproeve
TW364850B (en) Nematocidal compositions
DE69725850D1 (de) Analoge des parathormons zur behandlung der osteoporose
DE69634438D1 (de) Von humanem hitzeschockprotein 60 hergeleitete peptide zur behandlung von diabetis, entsprechende zusammensetzungen, verfahren und kits
HUP0104667A2 (hu) A csecsemőmirigy növekedését serkentő csecsemőtápszer
DE3853156D1 (de) Polyestergewebe zur herstellung von elektrophoresegelen und elektrophoresegel.
MXPA02000465A (es) Derivados ciclopeptidicos como inhibidores de la integrina alfav beta6.
DE69901690D1 (de) Verwendung von vip analoge für vorbeugung und behandlung von gehirnbeschädigungen von menschlichen neugeborenen
ATE218334T1 (de) Verwendung von gabapentin in der behandlung vonangst - und panikstörungen
ATE452903T1 (de) Modifizierte peptide und deren verwendung zur behandlung von autoimmunkrankheiten
DE69109293D1 (de) Verwendung von 20(r)-22-oxa-vitamin d analoge zur herstellung eines medikaments für die behandlung des altershaut.
ATE427955T1 (de) Zusammensetzungen und verfahren zur erfassung von stress induzierten proteinen
PT100299A (pt) Analogo de hirudina, metodo para a sua producao e anti-coagulante contendo-o, e vector de secrecao , microorganismos transformados com o referido vector e metodo para a producao de produtos a partir dos referidos microorganismos
DE69433763D1 (de) Lineare und cyklische peptide zur behandlung oder verhinderung von ekzem und dermatitis

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee